Vulvovaginal candidiasis: etiology, pathogenesis, diagnosis, treatment
https://doi.org/10.21518/2079-701X-2019-12-142-145
Abstract
The article represents the main problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). It is noted that C. albicans causes candidiasis in 75-80% of cases. Clinical forms of VVC include acute VVC and chronic (recurrent) vulvovaginal candidiasis (HRVVC). The main diagnostic approaches in the treatment and prevention of disease recurrence are described. The article presents data on the use of Clotrimazole vaginal cream 2% (Esparma) to treat VVC.
About the Authors
N. A. BuralkinaRussian Federation
Buralkina Nataliya Aleksandrovna - Dr. of Sci. (Med.), Senior Researcher, Surgery Department.
117997, Moscow, 4, Oparina str.; т. 8-926-405-62-83
O. V. Shabalova
Russian Federation
Shabalova Olga Valerievna
117997, Moscow, 4, Oparina str.
References
1. Federal clinical guidelines. Diagnosis and treatment of diseases involving pathological genital tract secretions of women, Moscow 2013. (In Russ).
2. Foxman B., Barlow R., D’Arcy H., Gillespie B., Sobel J.D. Candida vaginitis: self- reported incidence and associated costs. Sex Transm Dis. 2000;27:230-235.
3. Ogouyemi-Hounto A., Adisso S., Djamal J., Sanni R., Amangbegnon R., Biokou-Bankole B, Kinde Gazard D, Massougbodji A. Place of vulvovaginal candidiasis in the lower genital tract infections and associated risk factors among women in Benin. J Mycol Med. 2014 Jun;24(2):100-5.
4. Uvarova E.V. Vulvovaginal candidiasis in girls (guidelines for a practitioner). Antibiot Khimioter. 2007;52(4-5):49-55. [Article in Russian].
5. Hoffmann J.N., You H.M., Hedberg E.C., Jordan J.A., McClintock M.K. Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States. J Gerontol B Psychol Sci Soc Sci. 2014 Nov;69(Suppl 2):205-14.
6. Hamad M., Kazandji N., Awadallah S., Allam H. Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. Mycoses. 2014 Mar;57(3):184-90.
7. Guidelines for outpatient care in obstetrics and gynecology, under the editorship of Acad. V.I. Kulakov, Prof. V.N. Prilepskaya, V.E. Radzinsky GEOTAR-Media, 2006. p. 1029. (In Russ).
8. Nyirjesy P Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin North Am. 2008;22:637-52.
9. Baykushev R., Ouzounova-Raykova V., Stoykova V., Mitov I. Reliable microbiological diagnosis of vulvovaginal candidiasis. Akush Ginekol (Sofiia). 2014;53(4):17-20.
10. Bassyouni R.H., Wegdan A.A., Abdelmoneim A., Said W., AboElnaga F. Phospholipase and Aspartyl Proteinase Activities of Candida Species Causing Vulvovaginal Candidiasis in Patients with Type 2 Diabetes Mellitus. J Microbiol Biotechnol. 2015 Oct 28;25(10):1734-41.
11. Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG. 2015 May;122(6):785-94.
12. Beigi R.H., Meyn L.A., Moore D.M., Krohn M.A., Hillier S.L. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol. 2004;104:926-30.
13. Aguin TJ., Sobel J.D. Vulvovaginal candidiasis in pregnancy. Curr Infect Dis Rep. 2015 Jun;17(6):462.
14. Sexually Transmitted Diseases Treatment Guidelines, 2015, доступно на www. cdc. gov.
15. Zhou X., Li T., Fan S. et al. The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses. 2016 Apr 13.
Review
For citations:
Buralkina NA, Shabalova OV. Vulvovaginal candidiasis: etiology, pathogenesis, diagnosis, treatment. Meditsinskiy sovet = Medical Council. 2019;(12):142-145. (In Russ.) https://doi.org/10.21518/2079-701X-2019-12-142-145